We are live on
!
Find out more
GCM
Ghisallo Capital Management Portfolio holdings
AUM
$5.1B
1-Year Est. Return
39.13%
This Fund
S&P 500
This Quarter
Est. Return
+15.09%
1 Year Est. Return
+39.13%
3 Year Est. Return
+121.55%
5 Year Est. Return
+121.89%
10 Year Est. Return
–
AUM
$5.1B
AUM Growth
+$1.47B
(+40%)
Cap. Flow
+$410M
Cap. Flow
% of AUM
8.05%
Top 10 Holdings %
Top 10 Hldgs %
42.59%
Holding
458
New
148
Increased
12
Reduced
51
Closed
123
Avg Time Held
1.3
quarters
Top 10 Avg Time Held
0.3
quarters
Top 20 Avg Time Held
0.5
quarters
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SpaceX
SPCX
|
+$965M |
| 2 |
Digital Realty Trust
DLR
|
+$229M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$144M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$143M |
| 5 |
Super Micro Computer
SMCI
|
+$139M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$102M |
| 2 |
NVIDIA
NVDA
|
+$95.9M |
| 3 |
Microsoft
MSFT
|
+$92.5M |
| 4 |
GlobalFoundries
GFS
|
+$80.1M |
| 5 |
Medline Inc
MDLN
|
+$62.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 29.61% |
| 2 | Miscellaneous | 19.42% |
| 3 | Communication Services | 10.49% |
| 4 | Technology | 8.11% |
| 5 | Healthcare | 7.24% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Arrowhead Research
ARWR
$8.21B
| $4.89M | 0.1% |
+60,000
| New | +$4.43M |
2026 Q2
0 quarters
|
|
127
Karyopharm Therapeutics
KPTI
$9.69M
| $4.88M | 0.1% |
+500,000
| New | +$4.34M |
2026 Q2
0 quarters
|
|
128
Oaktree Acquisition Corp III Life Sciences
OACC
$264M
| $4.82M | 0.09% |
450,000
| – | – |
2025 Q1
5 quarters
|
|
129
Oruka Therapeutics
ORKA
$5.18B
| $4.76M | 0.09% |
+50,000
| New | +$3.33M |
2026 Q2
0 quarters
|
|
130
Bobs Discount Furniture
BOBS
$1.87B
| $4.75M | 0.09% |
300,000
| – | – |
2026 Q1
1 quarter
|
|
131
Tango Therapeutics
TNGX
$3.75B
| $4.69M | 0.09% |
+150,000
| New | +$3.71M |
2026 Q2
0 quarters
|
|
132
uniQure
QURE
$1.48B
| $4.61M | 0.09% |
+100,000
| New | +$2.62M |
2026 Q2
0 quarters
|
|
133
Infinite Eagle Acquisition Corp
IEAG
$439M
| $4.55M | 0.09% |
450,000
| – | – |
2026 Q1
1 quarter
|
|
|
CGCFU
134
Cartesian Growth Corporation IV Unit
CGCFU
| $4.5M | 0.09% |
+450,000
| New | +$4.5M |
2026 Q2
0 quarters
|
|
|
CCIX
135
DELISTED
Churchill Capital Corp IX
CCIX
| $4.36M | 0.09% |
400,000
| – | – |
2024 Q3
7 quarters
|
|
136
Forward Industries Inc
FWDI
$549M
| $4.25M | 0.08% |
1,006,882
| – | – |
2025 Q3
3 quarters
|
|
137
Gores Holdings X
GTEN
$470M
| $4.17M | 0.08% |
400,000
| – | – |
2025 Q2
4 quarters
|
|
138
Alamar Biosciences
ALMR
$1.63B
| $4.06M | 0.08% |
+150,000
| New | +$3.39M |
2026 Q2
0 quarters
|
|
139
MOZAYYX Acquisition Corp Units
MZYX.U
| $4.05M | 0.08% |
400,000
| – | – |
2026 Q1
1 quarter
|
|
140
Trailblazer Acquisition Corp
BLZR
$352M
| $4.05M | 0.08% |
400,000
| – | – |
2025 Q4
2 quarters
|
|
141
OneIM Acquisition Corp
OIM
$366M
| $4.03M | 0.08% |
400,000
| – | – |
2026 Q1
1 quarter
|
|
142
KRAKacquisition Corp
KRAQ
$433M
| $4M | 0.08% |
400,000
| – | – |
2026 Q1
1 quarter
|
|
143
The Elmet Group
ELMT
$649M
| $3.95M | 0.08% |
+200,000
| New | +$3.43M |
2026 Q2
0 quarters
|
|
144
Portland General Electric
POR
$5.24B
| $3.89M | 0.08% |
75,000
-75,000
| -50% | -$3.8M |
2026 Q1
1 quarter
|
|
145
Centuri Holdings
CTRI
$2.1B
| $3.78M | 0.07% |
125,000
-125,000
| -50% | -$4.03M |
2025 Q4
2 quarters
|
|
146
Mountain Lake Acquisition Corp II
MLAA
| $3.72M | 0.07% |
375,000
| – | – |
2026 Q1
1 quarter
|
|
147
Cantor Equity Partners IV
CEPF
$588M
| $3.64M | 0.07% |
350,000
| – | – |
2025 Q3
3 quarters
|
|
148
Liftoff Mobile
LFTO
$2.78B
| $3.6M | 0.07% |
+150,000
| New | +$3.89M |
2026 Q2
0 quarters
|
|
149
Velo3D Inc
VELO
$249M
| $3.51M | 0.07% |
+200,000
| New | +$3.47M |
2026 Q2
0 quarters
|
|
150
Taysha Gene Therapies
TSHA
$1.17B
| $3.44M | 0.07% |
+505,000
| New | +$2.99M |
2026 Q2
0 quarters
|
|
Similar funds
KACA
MRCP
CFO
YCM
BPCE
GIBU
ACM
BMO
Ghisallo Capital Management's Q2 2026 Portfolio in Review
As of Q2 2026, Ghisallo Capital Management held 458 positions worth $5.1B, up 40% from $3.63B the previous quarter. Its ten largest holdings account for 43% of the portfolio.
Ghisallo Capital Management deployed $410M of net new capital in Q2 2026, opening 148 new positions and adding to 12 existing holdings. Its largest new stake was SpaceX: 5,678,145 shares worth $970M.
By sector, the portfolio is most concentrated in Industrials at 30% of assets, up from 17% a quarter earlier, followed by Miscellaneous and Communication Services.
On the sell side, the largest reduction was Medline Inc, an estimated $62.3M trimmed.
- Ghisallo Capital Management's largest Q2 2026 buy was SpaceX: 5,678,145 shares worth $970M.
- Ghisallo Capital Management added most to Diamondback Energy in Q2 2026, an estimated $29.1M increase.
- Ghisallo Capital Management's biggest Q2 2026 reduction was Medline Inc, cutting an estimated $62.3M.
- Ghisallo Capital Management fully exited Tesla in Q2 2026, selling an estimated $102M.
- Ghisallo Capital Management's ten largest holdings make up 43% of its $5.1B portfolio in Q2 2026.
- Ghisallo Capital Management opened 148 new positions and closed 123 in Q2 2026.
- Ghisallo Capital Management's portfolio value rose 40% quarter-over-quarter to $5.1B.
Based on Ghisallo Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.